Skip to main content

Logo (Actavis) 422 Pill - gray round, 8mm

Pill with imprint Logo (Actavis) 422 is Gray, Round and has been identified as Lamotrigine Extended-Release 100 mg. It is supplied by Actavis Pharma, Inc.

Lamotrigine is used in the treatment of Bipolar Disorder; Lennox-Gastaut Syndrome; Seizure Prevention; Epilepsy; Seizures and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy. Lamotrigine 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Logo (Actavis) 422

Lamotrigine extended-release 100 mg Logo (Actavis) 422
Lamotrigine extended-release 100 mg Logo (Actavis) 422 Front
Lamotrigine extended-release 100 mg Logo (Actavis) 422 Back

Lamotrigine Extended-Release

Logo (Actavis) 422
100 mg
8.00 mm
Prescription only
Drug Class
Triazine anticonvulsants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Actavis Pharma, Inc.
National Drug Code (NDC)
Inactive Ingredients
hypromelloses, lactose monohydrate, magnesium stearate, methacrylic acid - methyl methacrylate copolymer (1:2), silicon dioxide, magnesium silicate, titanium dioxide, triethyl citrate, FD&C Blue No. 2, FD&C Red No. 40, FD&C Yellow No. 6, triacetin

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.